ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,464Medicare Part D Prescriptions Filled, Including Refills

Rank: 105 out of 783

$803K Total Retail Price of All Prescriptions

Rank: 95 out of 783

542 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 11,929 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
AMLODIPINE BESYLATE 732 669 1 5
LEVOTHYROXINE SODIUM 587 489 2 1
LOSARTAN POTASSIUM 531 490 3 18
SIMVASTATIN 476 398 4 3
SYNTHROID 469 440 5 47
PRAVASTATIN SODIUM 403 353 6 14
LISINOPRIL 383 339 7 4
ATORVASTATIN CALCIUM 354 306 8 11
FUROSEMIDE 295 263 9 7
OMEPRAZOLE 280 268 10 6
ATENOLOL 253 228 11 17
METOPROLOL SUCCINATE 214 197 12 13
METFORMIN HCL ER 206 160 13 64
FENOFIBRATE 175 120 14 66
CITALOPRAM HBR 172 161 15 19
POTASSIUM CHLORIDE 159 146 16 16
CRESTOR 156 142 17 27
CLOPIDOGREL 151 132 18 29
FLUTICASONE PROPIONATE 150 115 19 46
NIASPAN 142 114 20 140
ALENDRONATE SODIUM 137 119 21 25
EVISTA 128 124 22 92
GABAPENTIN 128 109 22 15
SERTRALINE HCL 126 121 24 22
KLOR-CON 10 125 109 25 102
ZETIA 122 108 26 80
WARFARIN SODIUM 122 122 26 10
HYDROCODONE-ACETAMINOPHEN 121 120 S3 28 2
RANITIDINE HCL 118 99 29 44
CLONIDINE HCL 116 113 30 60
ZOLPIDEM TARTRATE 112 112 31 23
HYDROCHLOROTHIAZIDE 112 112 31 12
SPIRIVA 105 94 33 59
GLIPIZIDE ER 101 88 34 84
CARVEDILOL 99 87 35 21
METOPROLOL TARTRATE 98 93 36 9
PANTOPRAZOLE SODIUM 97 88 37 30
JANUVIA 95 68 38 73
PLAVIX 94 84 39 51
LOSARTAN-HYDROCHLOROTHIAZIDE 87 87 40 53
KLOR-CON M20 84 73 41 48
PEN NEEDLE 83 67 42 103
NAMENDA 80 80 43 32
METFORMIN HCL 79 78 44 8
CYMBALTA 77 57 45 35
ALLOPURINOL 71 69 46 31
SPIRONOLACTONE 70 58 47 57
NEXIUM 70 56 47 28
GLIMEPIRIDE 68 55 49 34
LANTUS SOLOSTAR 67 53 50 91
ADVAIR DISKUS 66 66 51 50
MELOXICAM 66 59 51 37
TRIAMTERENE-HCTZ 64 60 53 42
NOVOLOG FLEXPEN 62 51 54 142
LANTUS 60 54 55 38
AMITRIPTYLINE HCL 59 43 R 56 77
ESCITALOPRAM OXALATE 58 58 57 54
FAMOTIDINE 57 55 58 55
FLUOXETINE HCL 56 46 59 45
BENAZEPRIL HCL 56 52 59 85
DONEPEZIL HCL 56 56 59 24
PROAIR HFA 54 42 62 56
FINASTERIDE 53 53 63 127
KLOR-CON M10 52 49 64 137
HUMALOG 50 39 65 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.